Cord For Life

05/27/2026

Recognizing World Fanconi Anemia Awareness Month

This May, we stand with the Fanconi anemia community and raise awareness for the role cord blood stem cells can play in treatment.

FDA-approved cord blood stem cell transplants may be used to treat inherited blood disorders, including Fanconi anemia.

Cord blood donation can help provide lifesaving stem cells for patients in need of a transplant. By donating, families may give another family hope for treatment, healing, and more time together.

Together, we support research, honor those affected, and strive for a cure.

Learn more:
cordforlife.com
800-869-8608

05/15/2026

💜 Wearing Purple for MPS Awareness Day

Today, the Cord for Life team is wearing purple to raise awareness for Sanfilippo Syndrome.

Umbilical cord blood is an FDA-approved cellular therapy used in hematopoietic stem cell transplants for many serious diseases. Donations help make these life-saving stem cells available to patients who may need a transplant.

By donating cord blood, families can help give others hope, options, and the possibility of a second chance.

👉 https://www.cordforlife.com/maternal-health-forms-3/

05/11/2026

Motherhood doesn’t come with instructions. It comes with moments that matter most.

From first smiles to messy milestones, you do everything you can to protect their future. Banking your baby’s cord blood and cord tissue is one way to prepare for the unexpected. It is a powerful resource that could support their health for years to come.

Even without a manual, you can still make choices that last a lifetime. 💗

Learn more about donating or private banking at www.cordforlife.com

05/05/2026

Major Milestone in Regenerative Medicine Research

Cord for Life® has completed enrollment and dosing for its FDA-authorized Phase 1 clinical trial evaluating an investigational umbilical cord blood-derived biological therapeutic for lower back pain associated with Sacroiliac Joint Syndrome.

Preliminary Phase 1a observations include a favorable early safety profile, no unexpected adverse events reported to date, symptom severity reduction among all nine participants within 3–6 months, and positive quality-of-life trends.

Subject to regulatory review, Cord for Life® anticipates initiating Phase 2 later this year to further evaluate dosing and expanded enrollment.

04/26/2026

One of the greatest challenges in cord blood transplantation is finding a suitable donor match—especially for patients from diverse or mixed ethnic backgrounds, where fewer matching units are available in public registries.

Why does this matter?
For many patients, finding a match is the difference between life and death. Patients in need of a life-saving transplant are most likely to find a match from someone with a similar genetic background. When a match isn’t available, treatment may be delayed—or not possible at all.

Cord blood donation helps expand access, giving more patients a chance at treatment for conditions like leukemia, sickle cell anemia, and other serious blood disorders.

By choosing to donate, you have the opportunity to help fill this gap and potentially save a life. Donation is completely free, and the process is simple to arrange ahead of delivery.

If you’d like to move forward, you can take the next step by filling out the required Maternal Health Forms at https://www.cordforlife.com/maternal-health-forms-3/

If you have any questions about the process, we’re here to help.

04/10/2026

https://www.livescience.com/health/reproductive-health/no-one-knows-what-they-are-researchers-discover-new-type-of-cell-thats-seen-only-during-pregnancy

A new map of the "maternal-fetal interface" reveals a new type of cell, as well as the types of cells most likely to be affected in conditions like preeclampsia.

03/28/2026

https://www.goodmorningamerica.com/wellness/story/dad-issues-urgent-plea-find-stem-cell-donor-131407216

Juan Uribe said he left his job last year to focus his efforts on his son Max.

03/20/2026

https://news.mit.edu/2026/improving-cartilage-repair-through-cell-therapy-0319

A new method can monitor iron in cells known as mesenchymal stromal cells (MSCs), which can help determine their ability to grow tissue for cartilage repair. The breakthrough could lead to regenerative therapies for joint diseases.

03/02/2026

https://health.ucdavis.edu/news/headlines/first-ever-in-utero-stem-cell-therapy-for-fetal-spina-bifida-repair-is-safe-study-finds/2026/02?

A UC Davis Health research team has safely performed the world’s first spina bifida treatment combining fetal surgery with stem cells, according to results from Phase 1 of an ongoing clinical trial. These results have been published today in The Lancet.